X0508 4 2024-04-05 0001533743 Processa Pharmaceuticals, Inc. PCSA 0001378166 Young David C/O PROCESSA PHARMACEUTICALS, INC. 7380 COCA COLA DRIVE, SUITE 106 HANOVER MD 21076 true true Pres. Research & Development false Common Stock 2024-04-05 4 M 0 1675 A 81061 D Common Stock 2024-04-05 4 F 0 518 2.79 D 80543 D Common Stock 2024-07-10 4 M 0 644 A 81187 D Common Stock 2024-07-10 4 F 0 282 1.71 D 80905 D Common Stock 30985 I By Young-Plaisance Revocable Trust Common Stock 10786 I By Family Entities Common Stock 18544 I By CorLyst, LLC Restricted Stock Units 0 2024-06-28 4 A 0 3233 0 A Common Stock 3233 21922 D Restricted Stock Units 0 2024-06-28 4 A 0 2425 0 A Common Stock 2425 24347 D Restricted Stock Units 0 2024-06-28 4 A 0 404 0 A Common Stock 404 24751 D Restricted Stock Units 0 2024-06-28 4 A 0 404 0 A Common Stock 404 25155 D Distribution of vested restricted shares. Each Restricted Stock Unit represents a contingent right receive one share of the Issuer's common stock, following its vesting on January 1, 2025. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2025, and one-thirty-sixth each month thereafter until fully vested on January 1, 2027. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals. /s/s David Young by Michael B. Kirwan, as Attorney-in-Fact 2024-08-02